OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Thymoquinone Inhibits JAK/STAT and PI3K/Akt/ mTOR Signaling Pathways in MV4-11 and K562 Myeloid Leukemia Cells
Futoon Abedrabbu Al-Rawashde, Abdullah Saleh Al-wajeeh, Mansoureh Nazari, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 9, pp. 1123-1123
Open Access | Times Cited: 13
Futoon Abedrabbu Al-Rawashde, Abdullah Saleh Al-wajeeh, Mansoureh Nazari, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 9, pp. 1123-1123
Open Access | Times Cited: 13
Showing 13 citing articles:
Potential anticancer properties and mechanisms of thymoquinone in colorectal cancer
Farhad Sheikhnia, Vahid Rashidi, Hossein Maghsoudi, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 16
Farhad Sheikhnia, Vahid Rashidi, Hossein Maghsoudi, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 16
Indirubin, an Active Component of Indigo Naturalis, Exhibits Inhibitory Effects on Leukemia Cells via Targeting HSP90AA1 and PI3K/Akt Pathway
Yuanzhi Yao, Xiaoying Li, Xiaoqin Yang, et al.
Anti-Cancer Agents in Medicinal Chemistry (2024) Vol. 24, Iss. 9, pp. 718-727
Closed Access | Times Cited: 5
Yuanzhi Yao, Xiaoying Li, Xiaoqin Yang, et al.
Anti-Cancer Agents in Medicinal Chemistry (2024) Vol. 24, Iss. 9, pp. 718-727
Closed Access | Times Cited: 5
Multi-omics integration reveals immune hallmarks and biomarkers associated with FLT3 inhibitor sensitivity in FLT3-mutated AML
Mingming Niu, Ning Wang, Dandan Yang, et al.
Blood Science (2025) Vol. 7, Iss. 2, pp. e00227-e00227
Open Access
Mingming Niu, Ning Wang, Dandan Yang, et al.
Blood Science (2025) Vol. 7, Iss. 2, pp. e00227-e00227
Open Access
Modulating the JAK/STAT pathway with natural products: potential and challenges in cancer therapy
Bhagyalakshmi Nair, Anjana Menon, Mamta Kalidas, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Bhagyalakshmi Nair, Anjana Menon, Mamta Kalidas, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Thymoquinone Enhances Apoptosis of K562 Chronic Myeloid Leukemia Cells through Hypomethylation of SHP-1 and Inhibition of JAK/STAT Signaling Pathway
Futoon Abedrabbu Al-Rawashde, Ola M. Al-Sanabra, Moath Alqaraleh, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 6, pp. 884-884
Open Access | Times Cited: 5
Futoon Abedrabbu Al-Rawashde, Ola M. Al-Sanabra, Moath Alqaraleh, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 6, pp. 884-884
Open Access | Times Cited: 5
Immune-Stimulating Potential of Lacticaseibacillus rhamnosus LM1019 in RAW 264.7 Cells and Immunosuppressed Mice Induced by Cyclophosphamide
Yeji You, Sung Hwan Kim, Chulhong Kim, et al.
Microorganisms (2023) Vol. 11, Iss. 9, pp. 2312-2312
Open Access | Times Cited: 5
Yeji You, Sung Hwan Kim, Chulhong Kim, et al.
Microorganisms (2023) Vol. 11, Iss. 9, pp. 2312-2312
Open Access | Times Cited: 5
Involvement of Nrf2, JAK and COX pathways in acetaminophen-induced nephropathy: Role of some antioxidants
Qamraa H. Alqahtani, Laila M. Fadda, Ahlam M. Alhusaini, et al.
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 10, pp. 101752-101752
Open Access | Times Cited: 4
Qamraa H. Alqahtani, Laila M. Fadda, Ahlam M. Alhusaini, et al.
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 10, pp. 101752-101752
Open Access | Times Cited: 4
Targeting FMS-like tyrosine kinase 3 (FLT3) in acute myeloid leukemia: Novel molecular approaches and therapeutic challenges
Jan Rataj, Lukáš Górecki, Darina Muthná, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 182, pp. 117788-117788
Open Access | Times Cited: 1
Jan Rataj, Lukáš Górecki, Darina Muthná, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 182, pp. 117788-117788
Open Access | Times Cited: 1
The Mechanism of Anti-Tumor Activity of 6-Morpholino- and 6-Amino-9-Sulfonylpurine Derivatives on Human Leukemia Cells
Marijana Jukić, Teuta Opačak‐Bernardi, Vesna Rastija, et al.
Molecules (2023) Vol. 28, Iss. 16, pp. 6136-6136
Open Access | Times Cited: 1
Marijana Jukić, Teuta Opačak‐Bernardi, Vesna Rastija, et al.
Molecules (2023) Vol. 28, Iss. 16, pp. 6136-6136
Open Access | Times Cited: 1
JAK/STAT as therapeutic signaling pathway in leukemia: a systematic review on in vitro inhibitors
Zahed Karimi, Samira Zakeri Shahvari, Katayoon Ghasemi, et al.
Research Square (Research Square) (2024)
Open Access
Zahed Karimi, Samira Zakeri Shahvari, Katayoon Ghasemi, et al.
Research Square (Research Square) (2024)
Open Access
JAK/STAT signaling pathway inhibitors for leukemia therapeutic potential : a systematic review on in vitro literatures
Zahed Karimi, Samira Zakeri Shahvari, Katayoon Ghasemi, et al.
Research Square (Research Square) (2024)
Open Access
Zahed Karimi, Samira Zakeri Shahvari, Katayoon Ghasemi, et al.
Research Square (Research Square) (2024)
Open Access
Lung cancer exosomal Gal3BP promotes osteoclastogenesis with potential connotation in osteolytic metastasis
Pratyusha Ghanta, Evin Hessel, Andrea Arias-Alvarado, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Pratyusha Ghanta, Evin Hessel, Andrea Arias-Alvarado, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Molecular Implications of BCR-ABL1 in Hematological Malignancies
Caio Bezerra Machado, Flávia Melo Cunha de Pinho Pessoa, Raquel Carvalho Montenegro, et al.
Elsevier eBooks (2023), pp. 315-329
Closed Access
Caio Bezerra Machado, Flávia Melo Cunha de Pinho Pessoa, Raquel Carvalho Montenegro, et al.
Elsevier eBooks (2023), pp. 315-329
Closed Access
